US20010016758A1 - Implantable defibrillator apparatus - Google Patents
Implantable defibrillator apparatus Download PDFInfo
- Publication number
- US20010016758A1 US20010016758A1 US09/843,511 US84351101A US2001016758A1 US 20010016758 A1 US20010016758 A1 US 20010016758A1 US 84351101 A US84351101 A US 84351101A US 2001016758 A1 US2001016758 A1 US 2001016758A1
- Authority
- US
- United States
- Prior art keywords
- electrodes
- defibrillation
- control unit
- shocks
- defibrillation shocks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000035939 shock Effects 0.000 claims abstract description 51
- 210000004165 myocardium Anatomy 0.000 claims abstract description 11
- 230000002861 ventricular Effects 0.000 claims description 11
- 206010003658 Atrial Fibrillation Diseases 0.000 claims description 10
- 206010061592 cardiac fibrillation Diseases 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 7
- 230000002600 fibrillogenic effect Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 230000005684 electric field Effects 0.000 claims description 5
- 210000003484 anatomy Anatomy 0.000 claims description 4
- 230000001360 synchronised effect Effects 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 1
- 230000001746 atrial effect Effects 0.000 description 8
- 230000002107 myocardial effect Effects 0.000 description 4
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000000739 chaotic effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005405 multipole Effects 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 2
- 239000003416 antiarrhythmic agent Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000036279 refractory period Effects 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3918—Heart defibrillators characterised by shock pathway, e.g. by electrode configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/395—Heart defibrillators for treating atrial fibrillation
Definitions
- the present invention relates to defibrillation techniques, and in particular relates to atrial defibrillation.
- Atrial fibrillation in its chronic and paroxysmal forms, constitutes the arrhythmia that is most frequent in the population, with a particularly high incidence (10%) in adults aged over 65 years.
- AF Atrial fibrillation
- the subject of an alternative solution becomes important.
- a defibrillator with an associated ventricular stimulation/sensing capability constitutes a recent treatment which is currently at the clinical evaluation stage.
- a defibrillator of this type is usually implanted by the insertion in the heart of two electrodes (leads) having large active surface areas and constituted by metal coils which are positioned along the outer wall of the right atrium and in the coronary sinus, whilst the metal container of the defibrillator can also operate as an active pole during discharge.
- the basic object of defibrillation is to produce an electric field adequate to involve, anatomically, a significant portion of the myocardium of both atria, in order to depolarize, by means of the electric shock, a predominant number of myocardial cells which are subject to spontaneous, chaotic and non-synchronized electrical activity.
- Recent tests have shown the great importance of the distribution of the electric field in minimizing defibrillation energy and consequently voltage, muscle-stimulation and perception of pain, which constitutes the most important factor limiting the use of these devices.
- the object of the present invention is to provide a defibrillator which can achieve an effective action antagonistic to fibrillation.
- this invention is an implantable defibrillator apparatus comprising a plurality of defibrillation electrodes adapted to be applied to the heart muscle and to deliver electric defibrillation shocks thereto, the plurality of electrodes in communication with defibrillation-control means capable of selectively supplying voltage pulses to the electrodes, wherein the defibrillation control means controls the duration and interval of the voltage pulses and further wherein the voltage pulses produce electric defibrillation shocks sufficient to produce defibrillation.
- the electric defibrillation shocks are sufficient to produce defibrillation synchronized with the heart's QRS, and the control unit can deliver defibrillation shocks to the electrodes in a desired time sequence.
- the control unit may selectively vary at least one characteristic of the electric defibrillation shocks, including the waveform of the defibrillation shock, the duration of the defibrillation shock, the interval between successive defibrillation shocks, and the electrodes to which a defibrillation shock is applied at any particular time.
- the apparatus may also comprise sensor means for detecting the occurrence of a fibrillation phenomenon, the sensor means being connected to the control unit and adapted to activate the application of defibrillation shocks.
- the sensor means may comprise respective sensing lines that connect the plurality of electrodes to the control unit to enable the electrodes to act both as defibrillation electrodes and as sensing electrodes.
- the apparatus may also comprise sensor means capable of detecting a ventricular electrogram.
- the control unit may synchronize the application of defibrillation shock during the QRS of the electrogram.
- this invention is an implantable defibrillator apparatus comprising a plurality of defibrillation electrodes adapted to be applied to the heart muscle and to deliver electric defibrillation shocks thereto; the plurality of electrodes in communication with electronic switches; the electronic switches in communication with a power stage capable of supplying voltage pulses to the electrodes, wherein the power stage is connected to a control unit that controls the duration and interval of the voltage pulses and further wherein the voltage pulses are applied for a time sufficient to produce defibrillation.
- this invention is a method of treating atrial fibrillation comprising providing a stimulating device having a plurality of electrodes; inserting the plurality of electrodes at desired locations in the heart; and applying defibrillation shocks to the plurality of electrodes in a desired sequence, thereby creating an electric field having a geometry designed for the patient's anatomy.
- Sensing atrial fibrillation may be done by means of the plurality of electrodes or by means of a specialized sensor.
- FIG. 1 shows a block diagram of the circuit structure of a multi-pole defibrillator according to the invention.
- the solution according to the invention enables the atrial defibrillation shock to be split up physically and over time so as to reduce the energy delivered.
- the implantable atrial defibrillator of this invention comprises at least two electrodes that can be inserted permanently in the heart chambers.
- Each electrode has a surface area ranging from 50 to 100 mm 2 .
- the electrodes permit the delivery of electric shocks in a programmable manner, sequentially in time, between any electrode or pole or group of electrodes or poles belonging to the same or to different leads, in order to defibrillate the fibrillating atria in an optimal manner.
- the electrical characteristics of the shock and, in particular, the waveforms (single-phase, symmetric two-phase and asymmetric two-phase, etc.), the duration, and the interval between successive shocks (on the order of about 100 microseconds) can be programmed.
- the sequence of defibrillation discharges is activated by sensing of the ventricular electrogram, detected by a suitable lead located in the right ventricle. This activation takes place in synchronism with the so-called QRS of the electrocardiograph signal to prevent dangerous proarrhythmia.
- the sequence has a programmable duration, by way of indication, no longer than 50 milliseconds, such that it is sure to be included within in the absolute refractory period of the ventricular myocardium.
- FIG. 1 shows a plurality of electrodes (or “poles”), indicated 1 , 2 , 3 , . . . n, that can be fitted in sites of the heart suitable for bringing about an effect antagonistic to fibrillation (defibrillation), particularly with regard to atrial fibrillation (AF), by the application of electric signals (shocks).
- electrodes or “poles”
- the term “electrode” or “pole” as used herein is intended to define any electrically-conductive member which can be associated with the heart muscle in a relationship suitable for the transmission of an electrical signal. Consequently, the electrodes or poles in question may either be configured as physically separate members which are thus intended to be fitted in distinct and separate respective myocardial sites, or may be associated in groups or sets with respective supporting structures (so-called “leads”) so as to be fitted in respective myocardial sites separately (in the sense that each electrode or pole can transfer—and detect—a respective signal to— and from—the myocardium) but not independently, since the electrodes or poles of each group disposed on a respective lead are implanted simultaneously as a result of the implantation of the respective supporting element.
- the apparatus may comprise two electrodes, or in more complex configurations, the number n may equal, for example, ten electrodes. Preferred numbers of electrodes typically range from three to five. Electrodes 1 to n may either be identical to one another or may have different shapes according to the sites in which they are to be positioned.
- electrodes 1 to n preferably have a surface area typically of the order of 50 mm 2 or more, for example, 100 mm 2 . Since, as mentioned above, the functional relationship between impedance and surface area of a conductor pole immersed in blood is typically hyperbolic, with surface-area values of the type indicated, a low shock voltage (for example 50 to 100 volts) suffices to produce a current density in each of the electrodes equal to that which required the application of voltages even three to four times greater in the (single) electrodes of known implantable defibrillators.
- a low shock voltage for example 50 to 100 volts
- the apparatus comprises defibrillation control means having power stage 4 ; electrodes 1 , 2 , 3 , . . . to n; electronic enabling switches 11 , 12 , 12 , . . . , in; and timing and control unit 37 , whose operation is described as follows.
- Power stage (the “high voltage” stage) 4 of the implantable defibrillator generates voltage pulses which are applied to electrodes 1 , 2 , 3 , . . . to n, via respective electronic enabling switches or control gates 11 , 12 , 13 , . . . , 1 n.
- Switches or control gates 11 to 1 n are connected to respective enabling lines 21 , 22 , 23 , . . . , 2 n, thus allowing the signals generated in power stage 4 to pass selectively towards electrodes 1 , 2 , . . . n).
- Switches or control gates 11 to 1 n communicate with and are controlled by timing and control unit 37 , preferably provided with telemetering interface 37 a of generally known type.
- control unit 37 by means of lines 21 , 22 , 23 , . . . 2 n enables the characteristics of the defibrillation signals applied to the myocardium to be programmed, in particular with regard to the following characteristics:
- the waveform single-phase, symmetric two-phase and asymmetric two-phase, etc.
- the above-described multi-pole configuration permits, in particular, the creation of an electric defibrillation field of variable geometry designed for the patient's anatomy, by virtue of the ability to program the emission of the control signals by control unit 37 .
- This permits a further reduction in the intensity (in practice, the voltage) of the signals applied; this results in an ability to achieve effective atrial defibrillation with low pain perception since the latter is caused mainly by the voltage.
- the defibrillation may be activated by sensing of the chaotic atrial activity in the presence of fibrillation, which may be detected by means of specialized sensor 5 of generally known type.
- specialized sensor 5 of generally known type.
- Respective sensing lines, generally indicated 6 are provided for this purpose and enable the electrical signals indicative of the local myocardial activity at the respective implant site to be detected by the respective electrode so as to supply to control unit 37 a set of signals which enables control unit 37 to see and to identify the occurrence of a fibrillation phenomenon.
- FIG. 1 shows multiplexer 7 , that enables the signal coming from one or more of electrodes 1 , 2 , 3 , . . . n, to be detected selectively by the respective sensing line 6 .
- the sensing signals After anti-noise filtering performed in filter 8 and automatic gain control performed in automatic gain-control circuit (AGC) 9 controlled by control unit 37 by means of line 10 , the sensing signals thus detected reach comparator circuit 30 .
- the sensing signals are compared with a threshold level, which may be adaptively modifiable, and which is supplied by control unit 37 by means of line 31 .
- a sensor (of known type), indicated 32 , can detect ventricular activity and can supply to the unit a corresponding synchronization signal such that control unit 37 can synchronize the application of the shock sequence by the electrodes 1 to n with the ventricular QRS.
- the sensing operation is regulated in a manner such as to prevent a sensing signal from being picked up from an electrode which is being used at the time in question for the application of a defibrillation signal.
- the sequence of defibrillation discharges is activated by sensing of the ventricular electrogram detected by sensor 32 , preferably located in the right ventricle, so as to have a programmable duration, by way of indication, no greater than 50 milliseconds, which is sure to be included within the absolute refractory period of the ventricular myocardium.
Abstract
An implantable defibrillator apparatus having a plurality of defibrillation electrodes which can be applied to the heart muscle in order to apply electric defibrillation shocks thereto, and defibrillation-control means for selectively applying respective electric defibrillation shocks to the electrodes preferably sequentially in time and in synchronism with the QRS.
Description
- This is a continuation of application Ser. No. 09/299,699, filed Apr. 26, 1999, the contents of which are hereby incorporated herein by reference.
- The present invention relates to defibrillation techniques, and in particular relates to atrial defibrillation.
- Atrial fibrillation (often referred to simply as AF), in its chronic and paroxysmal forms, constitutes the arrhythmia that is most frequent in the population, with a particularly high incidence (10%) in adults aged over 65 years. There is no pharmacological treatment which is sure to be effective and, as for all antiarrhythmic drugs, there is an increased probability of inducing serious ventricular proarrhythmia. In patients who are suffering from this condition to an incapacitating extent and who do not respond to the use of an average of two to three antiarrhythmia drugs, the subject of an alternative solution becomes important.
- An implantable atrial defibrillator with an associated ventricular stimulation/sensing capability constitutes a recent treatment which is currently at the clinical evaluation stage. A defibrillator of this type is usually implanted by the insertion in the heart of two electrodes (leads) having large active surface areas and constituted by metal coils which are positioned along the outer wall of the right atrium and in the coronary sinus, whilst the metal container of the defibrillator can also operate as an active pole during discharge.
- The basic object of defibrillation is to produce an electric field adequate to involve, anatomically, a significant portion of the myocardium of both atria, in order to depolarize, by means of the electric shock, a predominant number of myocardial cells which are subject to spontaneous, chaotic and non-synchronized electrical activity. Recent tests have shown the great importance of the distribution of the electric field in minimizing defibrillation energy and consequently voltage, muscle-stimulation and perception of pain, which constitutes the most important factor limiting the use of these devices.
- The object of the present invention is to provide a defibrillator which can achieve an effective action antagonistic to fibrillation.
- In one aspect, this invention is an implantable defibrillator apparatus comprising a plurality of defibrillation electrodes adapted to be applied to the heart muscle and to deliver electric defibrillation shocks thereto, the plurality of electrodes in communication with defibrillation-control means capable of selectively supplying voltage pulses to the electrodes, wherein the defibrillation control means controls the duration and interval of the voltage pulses and further wherein the voltage pulses produce electric defibrillation shocks sufficient to produce defibrillation. Preferably, the electric defibrillation shocks are sufficient to produce defibrillation synchronized with the heart's QRS, and the control unit can deliver defibrillation shocks to the electrodes in a desired time sequence. The control unit may selectively vary at least one characteristic of the electric defibrillation shocks, including the waveform of the defibrillation shock, the duration of the defibrillation shock, the interval between successive defibrillation shocks, and the electrodes to which a defibrillation shock is applied at any particular time. The apparatus may also comprise sensor means for detecting the occurrence of a fibrillation phenomenon, the sensor means being connected to the control unit and adapted to activate the application of defibrillation shocks. The sensor means may comprise respective sensing lines that connect the plurality of electrodes to the control unit to enable the electrodes to act both as defibrillation electrodes and as sensing electrodes. The apparatus may also comprise sensor means capable of detecting a ventricular electrogram. The control unit may synchronize the application of defibrillation shock during the QRS of the electrogram.
- In another aspect, this invention is an implantable defibrillator apparatus comprising a plurality of defibrillation electrodes adapted to be applied to the heart muscle and to deliver electric defibrillation shocks thereto; the plurality of electrodes in communication with electronic switches; the electronic switches in communication with a power stage capable of supplying voltage pulses to the electrodes, wherein the power stage is connected to a control unit that controls the duration and interval of the voltage pulses and further wherein the voltage pulses are applied for a time sufficient to produce defibrillation.
- In yet another aspect, this invention is a method of treating atrial fibrillation comprising providing a stimulating device having a plurality of electrodes; inserting the plurality of electrodes at desired locations in the heart; and applying defibrillation shocks to the plurality of electrodes in a desired sequence, thereby creating an electric field having a geometry designed for the patient's anatomy. Sensing atrial fibrillation may be done by means of the plurality of electrodes or by means of a specialized sensor.
- FIG. 1 shows a block diagram of the circuit structure of a multi-pole defibrillator according to the invention.
- Basically, the solution according to the invention enables the atrial defibrillation shock to be split up physically and over time so as to reduce the energy delivered.
- In a preferred embodiment, the implantable atrial defibrillator of this invention comprises at least two electrodes that can be inserted permanently in the heart chambers. Each electrode has a surface area ranging from 50 to 100 mm2. The electrodes permit the delivery of electric shocks in a programmable manner, sequentially in time, between any electrode or pole or group of electrodes or poles belonging to the same or to different leads, in order to defibrillate the fibrillating atria in an optimal manner.
- The electrical characteristics of the shock and, in particular, the waveforms (single-phase, symmetric two-phase and asymmetric two-phase, etc.), the duration, and the interval between successive shocks (on the order of about 100 microseconds) can be programmed.
- When atrial fibrillation has been confirmed by sensing of the chaotic atrial activity detectable by one or more poles of the same leads or by means of a specialized sensor, the sequence of defibrillation discharges is activated by sensing of the ventricular electrogram, detected by a suitable lead located in the right ventricle. This activation takes place in synchronism with the so-called QRS of the electrocardiograph signal to prevent dangerous proarrhythmia. The sequence has a programmable duration, by way of indication, no longer than 50 milliseconds, such that it is sure to be included within in the absolute refractory period of the ventricular myocardium.
- Since the functional relationship between impedance and surface area of a conductor pole immersed in blood is hyperbolic, for surface areas greater than about 50 to 100 mm2, reduced variations occur in impedance as a function of surface area. In the currently preferred solution for implementing the invention, a low shock voltage thus suffices to produce, at each of the above-described poles, a current density equal to that which requires voltages even three to four times greater in the single poles of large surface area which are used predominantly at the moment. It is consequently possible to achieve effective atrial defibrillation with reduced perception of pain, which is caused mainly by the voltage. The multi-pole configuration also permits the creation of an electric field of variable geometry designed for the patient's anatomy, which can further reduce the need for high voltages.
- The invention will now be described with reference to FIG. 1, which shows a plurality of electrodes (or “poles”), indicated1, 2, 3, . . . n, that can be fitted in sites of the heart suitable for bringing about an effect antagonistic to fibrillation (defibrillation), particularly with regard to atrial fibrillation (AF), by the application of electric signals (shocks).
- The structural characteristics of these electrodes, for example, the selection of constituent materials, any surface treatment, etc., are those currently used in known implantable defibrillators.
- In particular, the term “electrode” or “pole” as used herein is intended to define any electrically-conductive member which can be associated with the heart muscle in a relationship suitable for the transmission of an electrical signal. Consequently, the electrodes or poles in question may either be configured as physically separate members which are thus intended to be fitted in distinct and separate respective myocardial sites, or may be associated in groups or sets with respective supporting structures (so-called “leads”) so as to be fitted in respective myocardial sites separately (in the sense that each electrode or pole can transfer—and detect—a respective signal to— and from—the myocardium) but not independently, since the electrodes or poles of each group disposed on a respective lead are implanted simultaneously as a result of the implantation of the respective supporting element.
- The apparatus may comprise two electrodes, or in more complex configurations, the number n may equal, for example, ten electrodes. Preferred numbers of electrodes typically range from three to five. Electrodes1 to n may either be identical to one another or may have different shapes according to the sites in which they are to be positioned.
- In general, electrodes1 to n preferably have a surface area typically of the order of 50 mm2 or more, for example, 100 mm2. Since, as mentioned above, the functional relationship between impedance and surface area of a conductor pole immersed in blood is typically hyperbolic, with surface-area values of the type indicated, a low shock voltage (for example 50 to 100 volts) suffices to produce a current density in each of the electrodes equal to that which required the application of voltages even three to four times greater in the (single) electrodes of known implantable defibrillators.
- The apparatus comprises defibrillation control means having
power stage 4;electrodes 1, 2, 3, . . . to n; electronic enablingswitches - Power stage (the “high voltage” stage)4 of the implantable defibrillator generates voltage pulses which are applied to
electrodes 1, 2, 3, . . . to n, via respective electronic enabling switches orcontrol gates - Switches or
control gates 11 to 1 n are connected to respective enablinglines power stage 4 to pass selectively towards electrodes 1, 2, . . . n). Switches orcontrol gates 11 to 1 n communicate with and are controlled by timing and control unit 37, preferably provided with telemetering interface 37 a of generally known type. - The control performed by control unit37 by means of
lines - the waveform: single-phase, symmetric two-phase and asymmetric two-phase, etc.,
- the duration of each shock,
- the interval between successive shocks, and
- the ability to activate the defibrillation pulses in the
various electrodes 1, 2, 3, . . . , n sequentially in time (in accordance with a typical time-sharing scheme). - As a result, the above-described multi-pole configuration permits, in particular, the creation of an electric defibrillation field of variable geometry designed for the patient's anatomy, by virtue of the ability to program the emission of the control signals by control unit37. This permits a further reduction in the intensity (in practice, the voltage) of the signals applied; this results in an ability to achieve effective atrial defibrillation with low pain perception since the latter is caused mainly by the voltage.
- The defibrillation may be activated by sensing of the chaotic atrial activity in the presence of fibrillation, which may be detected by means of
specialized sensor 5 of generally known type. However, in a particularly preferred embodiment of the invention, it is possible to replace and/or to supplement this conventional sensing with sensing performed by theelectrodes 1, 2, 3, . . . n themselves. Respective sensing lines, generally indicated 6, are provided for this purpose and enable the electrical signals indicative of the local myocardial activity at the respective implant site to be detected by the respective electrode so as to supply to control unit 37 a set of signals which enables control unit 37 to see and to identify the occurrence of a fibrillation phenomenon. - The block diagram of FIG. 1 shows multiplexer7, that enables the signal coming from one or more of
electrodes 1, 2, 3, . . . n, to be detected selectively by the respective sensing line 6. After anti-noise filtering performed in filter 8 and automatic gain control performed in automatic gain-control circuit (AGC) 9 controlled by control unit 37 by means ofline 10, the sensing signals thus detectedreach comparator circuit 30. Here, the sensing signals are compared with a threshold level, which may be adaptively modifiable, and which is supplied by control unit 37 by means ofline 31. - Finally, a sensor (of known type), indicated32, can detect ventricular activity and can supply to the unit a corresponding synchronization signal such that control unit 37 can synchronize the application of the shock sequence by the electrodes 1 to n with the ventricular QRS.
- Moreover, the various electronic components shown in the drawing (or at least those of low power) clearly may either be in the form of discrete blocks or components, or may be integrated in a single circuit.
- According to known criteria, the sensing operation is regulated in a manner such as to prevent a sensing signal from being picked up from an electrode which is being used at the time in question for the application of a defibrillation signal. In particular, as already mentioned, the sequence of defibrillation discharges is activated by sensing of the ventricular electrogram detected by
sensor 32, preferably located in the right ventricle, so as to have a programmable duration, by way of indication, no greater than 50 milliseconds, which is sure to be included within the absolute refractory period of the ventricular myocardium. - Naturally, the principle of the invention remaining the same, the details of construction and forms of embodiment may be varied widely with respect to those described and illustrated, without thereby departing from the scope of the present invention, as defined by the following claims.
Claims (20)
1. An implantable defibrillator apparatus comprising:
a plurality of defibrillation electrodes adapted to be applied to the heart muscle and to deliver electric defibrillation shocks thereto;
the plurality of electrodes in communication with defibrillation-control means capable of selectively supplying voltage pulses to the electrodes; and
wherein the defibrillation control means controls the duration and interval of the voltage pulses and further wherein the voltage pulses produce electric defibrillation shocks sufficient to produce defibrillation.
2. The implantable defibrillator apparatus of wherein the electric defibrillation shocks are sufficient to produce defibrillation synchronized with the heart's QRS.
claim 1
3. An apparatus according to , wherein the control unit is adapted to deliver defibrillation shocks to the electrodes in a desired time sequence.
claim 1
4. An apparatus according to , wherein the control unit is adapted to selectively vary at least one characteristic of the electric defibrillation shocks, the at least one characteristic selected from the group of waveform of the defibrillation shock, the duration of the defibrillation shock, the interval between successive defibrillation shocks, and the electrodes to which a defibrillation shock is applied at any particular time.
claim 1
5. An apparatus according to , wherein the apparatus further comprises sensor means for detecting the occurrence of a fibrillation phenomenon, the sensor means being connected to the control unit and adapted to activate the application of defibrillation shocks.
claim 1
6. An apparatus according to , wherein the sensor means comprise respective sensing lines that connect the plurality of electrodes to the control unit to enable the electrodes to act both as defibrillation electrodes and as sensing electrodes.
claim 5
7. An apparatus according to , wherein the apparatus further comprises sensor means capable of detecting a ventricular electrogram, and wherein the control unit synchronizes the application of defibrillation shock during the QRS of the electrogram.
claim 1
8. An implantable defibrillator apparatus comprising:
a plurality of defibrillation electrodes adapted to be applied to the heart muscle and to deliver electric defibrillation shocks thereto;
the plurality of electrodes in communication with electronic switches;
the electronic switches in communication with a power stage capable of supplying voltage pulses to the electrodes; and
wherein the power stage is connected to a control unit that controls the duration and interval of the voltage pulses and further wherein the voltage pulses are applied for a time sufficient to produce defibrillation.
9. An apparatus according to , wherein the control unit is adapted to deliver defibrillation shocks to the electrodes in a desired time sequence.
claim 8
10. An apparatus according to , wherein the control unit is adapted to selective vary at least one characteristic of the electric defibrillation shocks, the at least one characteristic selected from the group of waveform of the defibrillation shock, the duration of the defibrillation shock, the interval between successive defibrillation shocks, and the electrodes to which a defibrillation shock is applied at any particular time.
claim 8
11. An apparatus according to , wherein the successive defibrillation shocks are applied at intervals of approximately 100 microseconds.
claim 8
12. An apparatus according to , wherein the electrodes have a surface area ranging from about 50 mm2 to about 100 mm2.
claim 8
13. An apparatus according to , wherein the apparatus further comprises a sensor for detecting the occurrence of a fibrillation phenomenon, the sensor being connected to the control unit and adapted to activate the application of defibrillation shocks.
claim 8
14. An apparatus according to , wherein the sequence of defibrillation shocks has a duration no greater than approximately 50 milliseconds.
claim 13
15. An apparatus according to , wherein the sensor comprises respective sensing lines that connect the plurality of electrodes to the control unit to enable the electrodes to act both as defibrillation electrodes and as sensing electrodes.
claim 13
16. An apparatus according to , wherein the apparatus further comprises a sensor capable of detecting a ventricular electrogram, and wherein the control unit synchronizes the application of defibrillation shock during the QRS of the electrogram.
claim 8
17. A method of treating atrial fibrillation comprising:
providing a stimulating device having a plurality of electrodes;
inserting the plurality of electrodes at desired locations in the heart; and
applying defibrillation shocks to the plurality of electrodes in a desired sequence, thereby creating an electric field having a geometry designed for the patient's anatomy.
18. The method of further comprising the step of sensing atrial fibrillation by means of the plurality of electrodes.
claim 17
19. The method of further comprising the step of sensing atrial fibrillation by means of a specialized sensor.
claim 17
20. The method of wherein the step of applying defibrillation shocks further comprises a control unit in communication with plurality of electrodes, the control unit controlling the characteristics of the defibrillation shocks by means of one of the waveform, the duration, the interval between shocks, and the sequence of activating shocks to various electrodes.
claim 17
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/843,511 US6405084B2 (en) | 1999-01-28 | 2001-04-25 | Implantable atrial defibrillator apparatus |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99830034.7 | 1999-01-28 | ||
EP99830034A EP1023921A1 (en) | 1999-01-28 | 1999-01-28 | Implantable defibrillation apparatus |
EP99830034 | 1999-01-28 | ||
US09/299,699 US6226550B1 (en) | 1999-01-28 | 1999-04-26 | Implantable defibrillator apparatus |
US09/843,511 US6405084B2 (en) | 1999-01-28 | 2001-04-25 | Implantable atrial defibrillator apparatus |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/299,699 Continuation US6226550B1 (en) | 1999-01-28 | 1999-04-26 | Implantable defibrillator apparatus |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010016758A1 true US20010016758A1 (en) | 2001-08-23 |
US6405084B2 US6405084B2 (en) | 2002-06-11 |
Family
ID=8243245
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/299,699 Expired - Lifetime US6226550B1 (en) | 1999-01-28 | 1999-04-26 | Implantable defibrillator apparatus |
US09/843,511 Expired - Fee Related US6405084B2 (en) | 1999-01-28 | 2001-04-25 | Implantable atrial defibrillator apparatus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/299,699 Expired - Lifetime US6226550B1 (en) | 1999-01-28 | 1999-04-26 | Implantable defibrillator apparatus |
Country Status (2)
Country | Link |
---|---|
US (2) | US6226550B1 (en) |
EP (1) | EP1023921A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7749266B2 (en) | 2006-02-27 | 2010-07-06 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US7785341B2 (en) | 2004-02-27 | 2010-08-31 | Aortx, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US7991484B1 (en) * | 2007-05-15 | 2011-08-02 | Pacesetter, Inc. | Active fixation medical lead and related method and system |
US8057396B2 (en) | 2006-05-24 | 2011-11-15 | Phoenix Biomedical, Inc. | Device for assessing a cardiac valve |
US8142492B2 (en) | 2006-06-21 | 2012-03-27 | Aortx, Inc. | Prosthetic valve implantation systems |
US8147541B2 (en) | 2006-02-27 | 2012-04-03 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US8376865B2 (en) | 2006-06-20 | 2013-02-19 | Cardiacmd, Inc. | Torque shaft and torque shaft drive |
US8500799B2 (en) | 2006-06-20 | 2013-08-06 | Cardiacmd, Inc. | Prosthetic heart valves, support structures and systems and methods for implanting same |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1023921A1 (en) * | 1999-01-28 | 2000-08-02 | SORIN BIOMEDICA CARDIO S.p.A. | Implantable defibrillation apparatus |
EP1172125B1 (en) | 2000-07-11 | 2005-03-09 | SORIN BIOMEDICA CRM S.r.l. | An implantable heart stimulation system with automatic mode switching controlled by sympatho-vagal balance |
US20030097167A1 (en) * | 2001-11-13 | 2003-05-22 | Friedman Paul A. | Transesophageal cardiac probe and methods of use |
US20050107833A1 (en) | 2003-11-13 | 2005-05-19 | Freeman Gary A. | Multi-path transthoracic defibrillation and cardioversion |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3952750A (en) * | 1974-04-25 | 1976-04-27 | Mieczyslaw Mirowski | Command atrial cardioverting device |
US5224475A (en) * | 1991-11-20 | 1993-07-06 | Medtronic, Inc. | Method and apparatus for termination of ventricular tachycardia and ventricular fibrillation |
DE59209579D1 (en) * | 1992-06-17 | 1999-01-14 | Pacesetter Ab | Defibrillator / cardiovert |
US5800465A (en) * | 1996-06-18 | 1998-09-01 | Medtronic, Inc. | System and method for multisite steering of cardiac stimuli |
SE9603000D0 (en) * | 1996-08-16 | 1996-08-16 | Pacesetter Ab | Implantable apparatus |
US5855592A (en) * | 1997-04-24 | 1999-01-05 | Ep Technologies, Inc. | Systems and methods for multi-site cardiac defibrillation using multiple electrode structures |
EP1023921A1 (en) * | 1999-01-28 | 2000-08-02 | SORIN BIOMEDICA CARDIO S.p.A. | Implantable defibrillation apparatus |
-
1999
- 1999-01-28 EP EP99830034A patent/EP1023921A1/en not_active Withdrawn
- 1999-04-26 US US09/299,699 patent/US6226550B1/en not_active Expired - Lifetime
-
2001
- 2001-04-25 US US09/843,511 patent/US6405084B2/en not_active Expired - Fee Related
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8430925B2 (en) | 2004-02-27 | 2013-04-30 | Cardiacmd, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US7785341B2 (en) | 2004-02-27 | 2010-08-31 | Aortx, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US9168134B2 (en) | 2004-02-27 | 2015-10-27 | Cardiacmd, Inc. | Method for delivering a prosthetic heart valve with an expansion member |
US8728156B2 (en) | 2004-02-27 | 2014-05-20 | Cardiac MD, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US8128692B2 (en) | 2004-02-27 | 2012-03-06 | Aortx, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US8608770B2 (en) | 2004-02-27 | 2013-12-17 | Cardiacmd, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US8147541B2 (en) | 2006-02-27 | 2012-04-03 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US8403981B2 (en) | 2006-02-27 | 2013-03-26 | CardiacMC, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US7749266B2 (en) | 2006-02-27 | 2010-07-06 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US8585594B2 (en) | 2006-05-24 | 2013-11-19 | Phoenix Biomedical, Inc. | Methods of assessing inner surfaces of body lumens or organs |
US8057396B2 (en) | 2006-05-24 | 2011-11-15 | Phoenix Biomedical, Inc. | Device for assessing a cardiac valve |
US8376865B2 (en) | 2006-06-20 | 2013-02-19 | Cardiacmd, Inc. | Torque shaft and torque shaft drive |
US8500799B2 (en) | 2006-06-20 | 2013-08-06 | Cardiacmd, Inc. | Prosthetic heart valves, support structures and systems and methods for implanting same |
US8142492B2 (en) | 2006-06-21 | 2012-03-27 | Aortx, Inc. | Prosthetic valve implantation systems |
US7991484B1 (en) * | 2007-05-15 | 2011-08-02 | Pacesetter, Inc. | Active fixation medical lead and related method and system |
Also Published As
Publication number | Publication date |
---|---|
EP1023921A1 (en) | 2000-08-02 |
US6226550B1 (en) | 2001-05-01 |
US6405084B2 (en) | 2002-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5632267A (en) | Heart defibrillator and defibrillation method wherein defibrillation is achieved by high-frequency, low-energy pulses | |
EP1057497B1 (en) | Cardioversion arrangement | |
US6006131A (en) | Dual current pathway atrial defibrillation apparatus | |
US5797967A (en) | System and method to reduce defibrillation requirements | |
US5370665A (en) | Medical stimulator with multiple operational amplifier output stimulation circuits | |
US6470211B1 (en) | Method and apparatus for treating cardiac arrhythmia | |
EP1234597B1 (en) | His bundle sensing device and associated method | |
DE69723735T2 (en) | HEART PACEMaker SYSTEM FOR PREVENTING ATRIAL FIBRILLATIONS | |
AU757287B2 (en) | Cardioverter and method for cardioverting an atrial tachyarrhythmia while maintaining atrial pacing | |
CA1308170C (en) | Apparatus for defibrillating a heart | |
EP1064050B1 (en) | System for treating atrial arrhythmias | |
EP0060117A2 (en) | Synchronized intracardiac cardioverter | |
JPH05137801A (en) | Implantable electric-defibrillator for atrium and electric defibrillation /defibrillator, and implantable electric-defibrillator for atrial tachycardia and operating method terefor | |
WO1998013102A9 (en) | System to reduce defibrillation requirements | |
JPH1052507A (en) | Heart pacing device | |
CA2196432A1 (en) | Atrial defibrillator and method of use | |
JP2002500938A (en) | Tachycardia induction system using near-field T-wave detection | |
US6405084B2 (en) | Implantable atrial defibrillator apparatus | |
AU5800899A (en) | Cardioverter and method for cardioverting an atrial tachyarrhythmia in the presence of atrial pacing | |
EP0930914A1 (en) | Implantable defibrillator with improved testing of capability to defibrillate | |
US7155286B1 (en) | System and method for reducing pain associated with cardioversion shocks generated by implantable cardiac stimulation devices | |
US7321794B2 (en) | Method and system for treating atrial fibrillation | |
US20030163166A1 (en) | Implantable defibrillator design with optimized multipulse waveform delivery and method for using | |
US5813999A (en) | Implantable atrial defibrillator providing reduced cardioversion discomfort | |
Bunch et al. | Pacing and defibrillation: clinically relevant basics for practice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20140611 |